Adilbay, Dauren
Yuan, Avery
Romesser, Paul B.
Wong, Richard J.
Shah, Jatin P.
Shaha, Ashok R.
Tuttle, Michael R.
Patel, Snehal
Lee, Nancy Y.
Ganly, Ian
Funding for this research was provided by:
NIH/NCI (Cancer Center Support Grant P30 CA008748)
Article History
Received: 25 January 2022
Accepted: 26 April 2022
First Online: 18 May 2022
Disclosure
: Dauren Adilbay, Avery Yuan, Paul B. Romesser, Richard J. Wong, Jatin P. Shah, Ashok R. Shaha, Michael R. Tuttle, Snehal Patel, Nancy Y. Lee, and Ian Ganly declare no conflicts of interest pertinent to this work. Snehal G. Patel has a patent pending (PCT/US2016/026717: Methods of Cancer Detection Using PARPi-FL), holds equity in Summit Biomedical Imaging and ColdSteel Laser Inc., and has the following patents: US10,016,238B2: Apparatus, system and method for providing laser steering and focusing for incision, excision, and ablation of tissue in minimally invasive surgery; PCT/US2014/073053: Systems, methods, and apparatus for multichannel imaging of fluorescent sources in real time; PCT/US2015/065816: Cyclic peptides with enhanced nerve-binding selectivity, nanoparticles bound with said cyclic peptides, and use of same for real-time in vivo nerve tissue imaging; and PCT/US2016/066969: Imaging systems and methods for tissue differentiation, e.g., for intraoperative visualization. Nancy Lee reports advisory board participation for Merck, Merck EMD, Elsie, Mirati, and Roche.